Why the study?
High concentrations of arachidonic acid are used to study aspirin efficacy and can cause cell lysis, with clinical studies showing decreased responses in whole blood tests in the presence of clopidogrel.
Does arachidonic acid stimulation in platelet function tests cause unspecific cell lysis and ADP-dependent platelet activation?
Does arachidonic acid stimulation in platelet function tests cause unspecific cell lysis and ADP-dependent platelet activation?
Answers are grounded in this paper and cite their sources.
Arachidonic acid used in platelet function tests causes unspecific cell lysis and ADP release, which may confound the assessment of aspirin and clopidogrel efficacy.
The use of arachidonic acid (AA) to stimulate platelets is considered as a specific approach to study aspirin treatment efficacy. However, very high concentrations of AA are used, and it has been previously reported that AA can induce cell lysis in other settings. Several clinical studies have reported decreased responses to AA in whole blood tests in the presence of clopidogrel. Our aim was to investigate whether unspecific effects contribute to AA-induced aggregation and platelet activation in light transmission aggregometry (LTA) in platelet-rich plasma (PRP), and in assays using whole blood, multiple electrode aggregometry (MEA, Multiplate®), and flow cytometry. We report that cell lysis, especially of red blood cells, does occur at concentrations of AA used in the clinical tests and that ADP is very important for the AA-induced platelet activation responses. In flow cytometry, very limited platelet activation was detected before reaching AA concentrations in the millimolar range, where cell lysis also occurred, making it problematic to develop a reliable flow cytometry assay using AA as reagent. We conclude that cell lysis and ADP release contribute to AA-induced platelet responses, most markedly in whole blood assays. This finding could potentially explain some differences between studies comparing methods using whole blood and PRP and also how clopidogrel treatment could influence AA-induced aggregation results in previously published studies. Our findings highlight some issues with AA as reagent for platelet activation, which also have an impact on how platelet activation assays using AA should be interpreted.
No takes yet. Share an insight, caveat, or question.
Sofia Ramström (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: